WPI 3739 Pill - yellow round
Pill with imprint WPI 3739 is Yellow, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 12 mg. It is supplied by Watson Laboratories, Inc.
Hydromorphone is used in the treatment of Chronic Pain; Anesthetic Adjunct; Pain; Cough and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Hydromorphone 12 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3739
Hydromorphone Hydrochloride Extended-Release
- Imprint
- WPI 3739
- Strength
- 12 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-3739 (Discontinued)
- Inactive Ingredients
-
cellulose acetate,
copovidone,
hypromelloses,
ferrosoferric oxide,
ferric oxide yellow,
lactose monohydrate,
magnesium stearate,
polyethylene glycol,
propylene glycol,
sodium chloride,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
More about hydromorphone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (445)
- Drug images
- Latest FDA alerts (11)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
- Hydromorphone drug information
- Hydromorphone injection
- Hydromorphone rectal
- Hydromorphone (Injection) (Advanced Reading)
- Hydromorphone (Oral) (Advanced Reading)
Other brands
Dilaudid, Exalgo, Palladone, Dilaudid-HP
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.